Journal Watch
-
Dialysis removes Vitamin B6; supplements can help
A meta-analysis has found 24-56% Vitamin B6 deficiencies, a problem made worse by ESAs, some phosphate binders, and modern dialyzer membranes. B6 supplementation recommendations may need to be updated.
Read the abstract » | (added 2011-07-26)
Tags:
-
Choosing PD may mean fewer access procedures for you
In a study of 369 Canadians with ESRD, 224 (61%!) chose PD, and just 145 (39%) chose HD. After an average of 1.3 years, those who chose PD had significantly fewer access procedures. PD catheters were less likely to fail than HD access.
Read the abstract » | (added 2011-07-26)
Tags:
-
Ratios of Omega-6 to Omega-3 fats may impact health in kidney disease
Western diets tend to have too much omega 6 and not enough omega 3 fatty acids. In 145 people on standard in-center HD, having too much omega 6 was linked with significantly higher inflammation.
Read the abstract » | (added 2011-07-26)
Tags: Chronic kidney disease
-
Review: What do we know now about more-frequent HD?
Studies have shown since the 1960s that more-frequent dialysis improves outcomes. The recent Frequent Hemodialysis Network trials confirmed these findings. This article reviews the data.
Read the abstract » | (added 2011-07-26)
Tags:
-
With a nurse educator, more urgent-start patients choose self-care treatments
As many as half of people start dialysis with no prior plan for it. When a renal triage nurse sees these patients, the chances that they will opt for PD, home HD, or transplant was significantly higher.
Read the abstract » | (added 2011-07-26)
Tags:
-
PD with PKD: Yes, it's possible
A Chinese study matched 42 people with and 84 without PKD as they started PD. After 5 years, survival in both groups was the same. There was no difference in the rate of peritonitis, though the PKD group was more likely to get hernias.
Read the abstract » | (added 2011-06-21)
Tags:
-
Better survival on home HD than PD in England and Wales
A study from the UK compared 225 people on home HD from 1997 to 2005 with age and sex matched people on PD and standard HD. Those on home HD lived significantly longer than those on PD—even when the researchers adjusted for those who received transplants or were on the wait list.
Read the abstract » | (added 2011-06-21)
Tags:
-
Fresenius options education program boosts PD & venous access use
The 3,165 people who attended a treatment options program (TOPs) were more than 8 times more likely to choose PD than those who didn't attend—and twice as likely to get a fistula or graft if they chose HD. TOPs attendees were also more likely to survive the first 90 days of treatment.
Read the abstract » | (added 2011-06-21)
Tags:
-
NAC protects PD membrane from sugar damage in rats
Over time, caramelized sugars in PD fluid can scar the peritoneal membrane to the point where PD may no longer work. In a rat study, an antioxidant (N-acetylcysteine, or NAC) reduced this damage. NAC may one day prove to be a treatment for humans.
Read the abstract » | (added 2011-06-21)
Tags:
-
Statin use may boost PD survival
A new study from Korea has found that taking a statin drug to lower cholesterol helped people on PD live longer—whether or not they had diabetes. The researchers suggest that larger, randomized studies are now needed.
Read the abstract » | (added 2011-06-21)
Tags: